Fluorescence Resonance Energy Transfer Assay at the Crossroad: Urgent Reexamination of Assay Design for Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors

Documenti analoghi

• Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS‐CoV‐2 via Combined Experiments
  di: Jiankai Ye, et al.
  Pubblicazione: (2025)
• A Clinical Investigation Into the Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Vaccination in Children With Acute Lymphoblastic Leukemia
  di: Zhengcun Wu, et al.
  Pubblicazione: (2025)
• Comparative Analysis of Quan and Watanabe Pan‐Coronavirus Assays for Bat Coronavirus Diversity in Sarawak, East Malaysia
  di: Sultana Parvin Habeebur‐Rahman, et al.
  Pubblicazione: (2025)
• Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus‐2
  di: Da Sol Kim, et al.
  Pubblicazione: (2026)
• The Diverse Roles of Heparan Sulfate in RNA Virus Infections: Insights From Enterovirus A71, Severe Acute Respiratory Syndrome Coronavirus 2, and Chikungunya Virus
  di: Chun Hao Theo, et al.
  Pubblicazione: (2026)